Phase 4 Heart Disease Trial, Recruiting NCT07476859 Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia Condition: Heart Disease
Back to Heart Disease

Phase 4 Heart Disease Trial, Recruiting

NCT07476859
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 65 years of age or older
  • People who were admitted to hospital for a confirmed heart attack or serious cardiac event within the past 15 days
  • People who were found to have low iron levels at the time of that hospital admission or within 15 days after the heart event, based on specific blood test results (either low ferritin or low transferrin saturation)
  • People who are able to sign a written consent form before taking part

Who may not be able to join:

  • People who currently have an active cancer diagnosis
  • People who have been assessed as having a terminal or end-stage illness based on a specific scoring tool used by doctors (confirm with trial site)
  • People who were already known to have significantly reduced heart pumping function (called low ejection fraction) before the heart event, or who developed this during their hospital stay or within 15 days after the event
  • People who are on long-term dialysis or who have advanced kidney or liver failure
  • People who had severely low red blood cell levels at the time of the heart event or within 15 days after it
  • People who received iron treatment — either by injection or by mouth — at any point in the 12 months before the heart event
  • People who are known to have had a serious allergic reaction to the iron medication used in this trial or to similar injectable iron products
  • People who have a condition involving too much iron in the body or a problem with how the body processes iron
  • People who have an active widespread infection or bacteria in the bloodstream at the time of enrolment
  • People who are already taking part in another clinical trial that involves an experimental medication
  • People whose overall health situation, in the treating doctor's judgement, would make participation unsafe or difficult to manage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +34 686 10 70 71

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Registry
ClinicalTrials.gov
Start date
5 March 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change from baseline in health-related quality of life measured using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) index score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov